UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000004801
Receipt number R000005714
Scientific Title A Phase II Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (MLL-10)
Date of disclosure of the study information 2011/01/01
Last modified on 2021/09/02 20:25:58

No. Disposal Last modified on Item of update
1 Insert 2010/12/27 19:47:11
2 Update 2011/06/27 10:35:03 TEL
Last name of contact person
Last name of contact person
Address
Address
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2014/04/22 12:32:19 Last name of lead principal investigator
Address
Email
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of person sending information
4 Update 2014/09/12 23:53:09 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
5 Update 2015/07/27 09:12:23 Organization
Organization
Organization
Organization1
Address1
Tel1
Email1
6 Update 2016/01/05 10:28:36 Recruitment status
Last follow-up date
7 Update 2018/03/16 20:56:47 Name of primary person or sponsor
Organization
Category of Funding Organization
8 Update 2018/03/16 20:58:29 Last follow-up date
9 Update 2020/01/02 10:00:52 Stratification
10 Update 2020/01/02 10:07:02 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email1
Organization
Organization
Address
Address
Tel
Email
11 Update 2020/01/02 10:12:47 Recruitment status
Date of IRB
Last follow-up date
12 Update 2021/09/02 20:19:20 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
13 Update 2021/09/02 20:25:58 Results